Discover
IBIO
iBio, Inc.
1.41
1 x 1.29
2 x 1.46
bid
ask
+
0.00
0.00%
100 @ 09:15 AM
1.42 +0.01 (0.71%)
| Ytd | -26.94% | |
| 1y | 94.03% |
day range
0.56
52 week range
3.82
| Open | Prev Close | 1.41 | Low | High | Mkt Cap | 22.26M | |||
| Vol | 0.00 | Avg Vol | 978.92K | EPS | -0.58 | P/E | -2.43 | Forward P/E | -1.44 |
| Beta | 1.27 | Short Ratio | 1.92 | Inst. Own | 31.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-22 | 50-d Avg | 1.65 | 200-d Avg | 1.80 | 1yr Est | 3.60 |
| Income Statement | |||
| Operating Expenses | 8.37M | ||
| Research and Development Expense | 3.25M | ||
| Selling, General and Administrative Expense | 5.11M | ||
| Operating Income | -8.36M | ||
| Interest Expense | 22.00K | ||
| Net Income | -7.73M | ||
| Net Income Common Stock | -7.73M | ||
| Net Income Common Stock (USD) | -7.73M | ||
| Consolidated Income | -7.73M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -7.71M | ||
| Earning Before Interest & Taxes (USD) | -7.71M | ||
| Weighted Average Shares | 119.60M | ||
| Weighted Average Shares Diluted | 119.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 47.86M | ||
| Cash and Equivalents (USD) | 47.86M | ||
| Investments | 28.32M | ||
| Investments Current | 27.17M | ||
| Investments Non-Current | 1.16M | ||
| Current Assets | 77.25M | ||
| Property, Plant & Equipment Net | 5.08M | ||
| Total Assets | 85.83M | ||
| Debt Current | 532.00K | ||
| Total Debt | 2.33M | ||
| Current Liabilities | 6.50M | ||
| Debt Non-Current | 1.79M | ||
| Total Liabilities | 8.30M | ||
| Accumulated Retained Earnings (Deficit) | -354.67M | ||
| Accumulated Other Comprehensive Income | -21.00K | ||
| Shareholders Equity | 77.54M | ||
| Shareholders Equity (USD) | 77.54M | ||
| Assets Non-Current | 8.58M | ||
| Total Debt (USD) | 2.33M | ||
| Deferred Revenue | 1.15M | ||
| Goodwill and Intangible Assets | 1.83M | ||
| Liabilities Non-Current | 1.79M | ||
| Trade and Non-Trade Payables | 3.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 250.00K | ||
| Net Cash Flow from Financing | 28.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 18.96M | ||
| Capital Expenditure | -11.00K | ||
| Issuance (Purchase) of Equity Shares | 7.53M | ||
| Net Cash Flow from Investing | -3.11M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.10M | ||
| Net Cash Flow from Operations | -6.08M | ||
| Share Based Compensation | 377.00K | ||